Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.It has developed a process that uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell – known as extracellular vesicles, or EVs – to detect stage I cancer.Paul Blavin and Joseph Sedlak founded the Natick, Massachusetts-based company in 2018.

Biotechnology

Health Care

Therapeutics

Mercy BioAnalytics, Inc.

Dawn Mattoon

Toumy G.

Tim Membrino

Michael Smith

Diane Marcou

Research and Development

Leadership Team

Teams at Mercy BioAnalytics, Inc.

Research and Development

Leadership Team